ClinicalTrials.Veeva

Menu

TopQ Cut-off Score Validation Study for 3D OCT-1 Maestro

Topcon logo

Topcon

Status

Completed

Conditions

Subjects Presenting With Normal Eyes

Treatments

Device: 3D OCT-1 Maestro

Study type

Observational

Funder types

Industry

Identifiers

NCT02447133
Topcon 001-2015

Details and patient eligibility

About

The objective of this study is to validate the TopQ cutoff scores, which have been previously determined.

Full description

Scans with a TopQ score below the optimum cut-off should be considered to be poor or unacceptable quality, and scans with a TopQ score above the cut-off should be considered good or acceptable quality. The study will evaluate the predetermined cut-off values by investigating measurement variability of scans.

Enrollment

12 patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria

  1. Participants must be at least 18 years of age
  2. They must be able to complete all testing (all OCT scans)
  3. They must volunteer to be in the study and sign the consent form

Exclusion Criteria

  1. Subject with history of ocular disease or ocular pathology
  2. TopQ score from baseline OCT scan (i.e., without any ND filters) is below the cut-off value.

Trial design

12 participants in 1 patient group

Subjects Presenting With Normal Eyes
Description:
Subjects with no known ocular diseases will be scanned on the Maestro device
Treatment:
Device: 3D OCT-1 Maestro

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems